AT325614B - Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbonsäureestern - Google Patents
Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbonsäureesternInfo
- Publication number
- AT325614B AT325614B AT196973A AT196973A AT325614B AT 325614 B AT325614 B AT 325614B AT 196973 A AT196973 A AT 196973A AT 196973 A AT196973 A AT 196973A AT 325614 B AT325614 B AT 325614B
- Authority
- AT
- Austria
- Prior art keywords
- dihydropyridine
- amino
- new
- production
- acid esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2210650A DE2210650C3 (de) | 1972-03-06 | 1972-03-06 | 2-Amino-6-alkoxy-4,5-dihydropyridin-3,5-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
| DE19722260860 DE2260860A1 (de) | 1972-12-13 | 1972-12-13 | Verfahren zur herstellung von neuen 2-amino-6-alkylmercapto-4,5-dihydropyridinen sowie ihre verwendung als antihypertensiva |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA196973A ATA196973A (de) | 1975-01-15 |
| AT325614B true AT325614B (de) | 1975-10-27 |
Family
ID=25762843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT196973A AT325614B (de) | 1972-03-06 | 1973-03-06 | Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbonsäureestern |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3876646A (de) |
| JP (1) | JPS5626658B2 (de) |
| AT (1) | AT325614B (de) |
| CA (1) | CA985685A (de) |
| CH (1) | CH580591A5 (de) |
| CS (1) | CS179980B2 (de) |
| DD (1) | DD106832A5 (de) |
| DK (1) | DK135714C (de) |
| ES (1) | ES412320A1 (de) |
| FR (1) | FR2183673B1 (de) |
| GB (1) | GB1374551A (de) |
| HU (1) | HU167088B (de) |
| IE (1) | IE37367B1 (de) |
| IL (1) | IL41666A (de) |
| NL (1) | NL7303134A (de) |
| SE (1) | SE384206B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3951993A (en) * | 1972-03-06 | 1976-04-20 | Bayer Aktiengesellschaft | 2-Amino-4,5-dihydropyridine derivatives and process for their preparation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1923990C3 (de) * | 1969-05-10 | 1978-11-23 | Bayer Ag | Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern |
| DE2013431C3 (de) * | 1970-03-20 | 1979-12-20 | Bayer Ag, 5090 Leverkusen | 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester |
| DE1963186C3 (de) * | 1969-12-17 | 1979-02-15 | Bayer Ag, 5090 Leverkusen | Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester |
| DE2003146A1 (de) * | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
| DE2117572C3 (de) * | 1971-04-10 | 1980-03-20 | Bayer Ag, 5090 Leverkusen | Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
| DE2117571C3 (de) * | 1971-04-10 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
-
1973
- 1973-02-23 DD DD169020A patent/DD106832A5/xx unknown
- 1973-02-28 US US336481A patent/US3876646A/en not_active Expired - Lifetime
- 1973-03-02 CH CH313673A patent/CH580591A5/xx not_active IP Right Cessation
- 1973-03-02 JP JP2444873A patent/JPS5626658B2/ja not_active Expired
- 1973-03-02 IL IL41666A patent/IL41666A/en unknown
- 1973-03-05 IE IE343/73A patent/IE37367B1/xx unknown
- 1973-03-05 DK DK118273A patent/DK135714C/da active
- 1973-03-05 ES ES412320A patent/ES412320A1/es not_active Expired
- 1973-03-05 CA CA165,183A patent/CA985685A/en not_active Expired
- 1973-03-05 SE SE7303018A patent/SE384206B/xx unknown
- 1973-03-06 HU HUBA2940A patent/HU167088B/hu unknown
- 1973-03-06 FR FR7307920A patent/FR2183673B1/fr not_active Expired
- 1973-03-06 CS CS7300001590A patent/CS179980B2/cs unknown
- 1973-03-06 AT AT196973A patent/AT325614B/de not_active IP Right Cessation
- 1973-03-06 NL NL7303134A patent/NL7303134A/xx not_active Application Discontinuation
- 1973-03-06 GB GB1075573A patent/GB1374551A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2183673B1 (de) | 1976-12-03 |
| NL7303134A (de) | 1973-09-10 |
| ES412320A1 (es) | 1976-04-16 |
| CS179980B2 (en) | 1977-12-30 |
| IL41666A0 (en) | 1973-05-31 |
| DK135714C (da) | 1977-11-14 |
| GB1374551A (en) | 1974-11-20 |
| FR2183673A1 (de) | 1973-12-21 |
| JPS5626658B2 (de) | 1981-06-19 |
| CH580591A5 (de) | 1976-10-15 |
| DD106832A5 (de) | 1974-07-05 |
| HU167088B (de) | 1975-08-28 |
| JPS4899180A (de) | 1973-12-15 |
| SE384206B (sv) | 1976-04-26 |
| US3876646A (en) | 1975-04-08 |
| ATA196973A (de) | 1975-01-15 |
| IL41666A (en) | 1976-02-29 |
| DK135714B (da) | 1977-06-13 |
| CA985685A (en) | 1976-03-16 |
| IE37367B1 (en) | 1977-07-06 |
| IE37367L (en) | 1973-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT319969B (de) | Verfahren zur Herstellung von neuen Diphosphinsäureestern | |
| AT338425B (de) | Verfahren zur herstellung von neuen 7-acylamido-3-cephem-4-carbonsaurederivaten | |
| AT347612B (de) | Verfahren zur herstellung von neuen pregnan-21- saeure-derivaten | |
| AT321942B (de) | Verfahren zur herstellung von neuen o-äthyl-s-n-propyl-o-vinyl- -thionothiolphosphorsäureestern | |
| AT327942B (de) | Verfahren zur herstellung von neuen n-phenyl-carbaminsaure- beta -phenoxyathylestern | |
| AT327194B (de) | Verfahren zur herstellung von neuen 2-alkylamino-dihydropyridinen | |
| AT327384B (de) | Verfahren zur herstellung von neuen fusidinsaurederivaten | |
| AT331425B (de) | Verfahren zur herstellung von neuen d-2-halogen-6-methyl-8-subst.-methylergolinen | |
| AT327376B (de) | Verfahren zur herstellung von neuen 7-acylamido-7-methoxy-cephemcarbonsaurederivaten | |
| AT323420B (de) | Verfahren zur herstellung von poly-alpha-oxy-acrylsäure | |
| ATA532473A (de) | Verfahren zur herstellung von 7-amino-desacetoxy-cephalosporansaure | |
| AT334347B (de) | Verfahren zur herstellung von neuen phenoxymalonsaureestern | |
| AT323149B (de) | Verfahren zur herstellung von neuen 5-aroylpyrrolcarbonsäureglycerinestern | |
| AT327175B (de) | Verfahren zur herstellung von neuen diacetoxybenzoesaureestern | |
| AT340608B (de) | Verfahren zur herstellung von neuen 9-desoxy-prosta-5,9, (10),13-triensaurederivaten | |
| CH548396A (de) | Verfahren zur herstellung von neuen d-6-methyl-8-ergolin-(i)-ylessigsaeureamiden. | |
| AT338230B (de) | Verfahren zur herstellung von neuen, optisch aktiven 5-hydroxycyclopent-2-enessigsaureestern | |
| ATA569773A (de) | Verfahren zur herstellung von neuen 7beta-amino-cepham-3-on-4-carbonsaureverbindungen | |
| AT333723B (de) | Verfahren zur herstellung von neuen phenoxyalkancarbonsaurethiolestern | |
| AT329541B (de) | Verfahren zur herstellung von neuen 3-alkoxy-5-subst. phenylessigsauren | |
| AT323342B (de) | Verfahren zur herstellung von neuen pregnansäure-derivaten | |
| AT342217B (de) | Verfahren zur herstellung von neuen prostanoesaurederivaten | |
| AT341122B (de) | Verfahren zur herstellung von neuen prostanoesaurederivaten | |
| ATA123975A (de) | Verfahren zur herstellung von neuen prostanoesaurederivaten | |
| ATA532475A (de) | Verfahren zur herstellung von neuen optisch aktiven aminophenyl-athanolaminen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |